---
title: "Arcutis Biotherapeutics grants 143,500 RSUs, 37,000 stock options to new hires under inducement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295272046.md"
description: "Arcutis Biotherapeutics granted 143,500 restricted stock units and 37,000 stock options to 24 new hires under its 2022 Inducement Plan. The RSUs vest over four years with annual cliff vesting. The stock options, exercisable at $25.94 per share, have a 10-year term and vest over four years, with 25% vesting after one year and the remainder monthly."
datetime: "2026-08-07T20:00:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295272046.md)
  - [en](https://longbridge.com/en/news/295272046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295272046.md)
generator: "portal-rs"
---

# Arcutis Biotherapeutics grants 143,500 RSUs, 37,000 stock options to new hires under inducement plan

-   Arcutis Biotherapeutics granted 143,500 restricted stock units, with 37,000 stock options, to 24 newly hired employees under its 2022 Inducement Plan. \* RSUs vest over four years, with 25% vesting on each annual anniversary, subject to continued employment. \* Options vest over four years; 25% vests after one year, with the remainder vesting in equal monthly installments over three years. \* Options carry a 10-year term, with an exercise price of $25.94 per share, set on Aug. 3, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608071600PRIMZONEFULLFEED9805784) on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)

## Related News & Research

- [Arcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71](https://longbridge.com/en/news/296400256.md)
- [Top Arcutis Executive Makes Notable Move With Latest Stock Sale](https://longbridge.com/en/news/296664320.md)
- [ADM announces Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 15](https://longbridge.com/en/news/296399586.md)
- [Coeur Mining EVP, CFO Thomas S. Whelan disposes of 6,000 common shares worth USD 125,220](https://longbridge.com/en/news/296542146.md)
- [Patagonia Gold says Rio Negro labor authority orders temporary partial suspension at Calcatreu project](https://longbridge.com/en/news/296604755.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**